NYSE:CLDI | Cash Flow Statement | Calidi Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.16M
2026-03-31-$4.11M-$4.12M-$5,000.00$5.16M
2025-12-31-$4.06M-$5.04M-$79,000.00$340,000.00
2025-09-30-$5.15M
2025-06-30-$5.72M
2025-03-31-$4.99M-$7.13M-$7,000.00$8.11M
2024-12-31-$4.1M-$5.42M-$5,000.00$13.11M
2024-09-30-$5.05M
2024-06-30-$5.77M
2024-03-31-$7.23M-$3.83M-$5,000.00$3.01M
2023-12-31-$8.23M-$5.19M-$35,000.00-$2.96M
2023-09-30-$2.02M
2023-06-30-$12.5M
2023-03-31-$6.46M-$3.11M-$137,000.00$3.79M
2022-12-31-$7.76M-$3.88M-$161,000.00$4.32M
2022-09-30-$5.36M
2022-06-30-$4.58M
2022-03-31-$7.74M-$465,131.00$0.00$0.00
2021-09-30-$823,289.00
2021-06-30-$83,303.00-$118,804.00$213,804.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$19.91M-$21.29M-$170,000.00$17.46M
2024-12-31-$22.14M-$19.69M-$16,000.00$27.37M
2023-12-31-$29.22M-$26.98M-$478,000.00$29.04M
2022-12-31-$25.43M-$13.21M-$494,000.00$12.09M